Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-10-018502
Filing Date
2010-03-01
Accepted
2010-02-26 19:48:41
Documents
7
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 INVERNESS MEDICAL INNOVATIONS, INC. b78679e10vk.htm 10-K 2784345
2 EX-21.1 LIST OF SUBSIDIARIES OF THE COMPANY b78679exv21w1.htm EX-21.1 38101
3 EX-23.1 CONSENT OF BDO SEIDMAN, LLP b78679exv23w1.htm EX-23.1 2003
4 EX-31.1 SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER b78679exv31w1.htm EX-31.1 5726
5 EX-31.2 SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER b78679exv31w2.htm EX-31.2 6017
6 EX-32.1 SECTION 906 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL b78679exv32w1.htm EX-32.1 4130
7 GRAPHIC b78679b7867901.gif GRAPHIC 9069
  Complete submission text file 0000950123-10-018502.txt   2854406
Mailing Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453
Business Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453 7816473900
INVERNESS MEDICAL INNOVATIONS INC (Filer) CIK: 0001145460 (see all company filings)

EIN.: 043565120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16789 | Film No.: 10641626
SIC: 2835 In Vitro & In Vivo Diagnostic Substances